Notably, the reduction of SIRT1 promotes adipogenesis of the visceral adipose-derived stem cells (ASC), and patients with obesity exhibit significant lower SIRT1 mRNA expression in visceral ASC compared to subcutaneous ASC [17,55]. The gene discussed is SIRT1; the disease is obesity disorder.